CCG 0955--GEMCITABINE IN CHILDREN WITH LEUKEMIA OR NONHODGKIN'S LYMPHOMA

CCG 0955--吉西他滨治疗白血病或非霍奇金淋巴瘤儿童

• 批准号: 6278095
• 负责人: BEVERLY LANGE
• 金额: $ 2.4万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6278095
• 关键词: adolescence (12-20); antileukemic agent; antineoplastics; antiviral agents; child (0-11); clinical research; clinical trial phase I; clinical trials; human subject; human therapy evaluation; leukemia; neoplasm /cancer chemotherapy; neoplasm /cancer pharmacology; nonHodgkin's lymphoma; outcomes research; pediatric pharmacology

This is a phase I-II trial supported by the NIH through the Children's Cancer Group Phase I Grant. One adolescent girl has been treated at CHOP. She had a grade III liver toxicity and achieved a complete response. Three adolescent patients have been treated nationally. The MTD has not been reached.

这是一个由美国国立卫生研究院通过儿童基金会支持的I-II期试验